Novo Nordisk gets UK approval for daily Wegovy weight loss pill Jun 11, 2026 11:13AM
Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows Jun 9, 2026 02:31PM
Novo Nordisk (NVO) call put ratio 2.1 calls to 1 put Jun 8, 2026 03:09AM
Morgan Stanley on Eli Lilly (LLY): 'We see ~7% upside to '26 M+Z ests' Jun 5, 2026 07:38AM
TD Cowen raises global GLP-1 sales forecast to $150B by 2030 Jun 5, 2026 07:05AM
View Older Stories

Jun 4, 2026 08:42AM Veru partners with Novo Nordisk for obesity drug combination study
May 25, 2026 05:00AM Bernstein says this cheap EU pharma stock is "a value trap"
May 22, 2026 09:13AM Novo Nordisk targets two-thirds cut in drug launch times with AI
May 22, 2026 09:09AM Novo Nordisk receives EU committee recommendation for oral Wegovy pill
May 21, 2026 04:20AM Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK200 at Bernstein SocGen Group, 'why's it still a value trap in our view'
May 12, 2026 12:53PM FDA Commissioner Marty Makary to step down - Politico
May 12, 2026 06:28AM Novo Nordisk's Wegovy shows 21% weight loss regardless of response speed
May 12, 2026 06:25AM Novo Nordisk presents data on higher-dose Wegovy weight loss effects
May 11, 2026 09:15AM TD Cowen on Novo Nordisk (NVO): 'Meet Management Highlights Multiple NearTerm Opportunities'
May 11, 2026 08:43AM Cellular Intelligence acquires Novo Nordisk's Parkinson's cell therapy
May 7, 2026 02:15PM Novo Nordisk Eyes Large-Scale M&A Following Pfizer's Metsera Win - Semafor
May 6, 2026 07:45AM Novo sees generic Ozempic delayed in China until next year - Bloomberg
May 6, 2026 03:21AM Novo Nordisk (NVO) Misses Q1 EPS by 33c
May 5, 2026 12:30PM Novo Nordisk reports Q1 earnings on Wednesday: Analysts flag key focus topics
May 5, 2026 11:27AM Novo Nordisk (NVO) call put ratio 2.3 calls to 1 put with a focus on May 8 weekly options into quarter results
May 5, 2026 05:20AM Novo Nordisk (NVO) call put ratio 3.4 calls to 1 put with a focus on September 35 calls into quarter results
May 4, 2026 08:44AM Why Eli Lilly stock is down 3% today: FDA adverse event data explained
May 1, 2026 08:34AM Novo Nordisk rebrands diabetes tablet as Ozempic in US
Apr 30, 2026 04:19PM Lilly's Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays
Apr 30, 2026 09:23AM FDA proposes to exclude semaglutide, tirzepatide from compounding list
Apr 27, 2026 04:06PM Novo Nordisk gets FDA fast track status for ATTR heart disease drug
Apr 24, 2026 07:27AM Morgan Stanley Comments on Eli Lilly (LLY) Amid Premarket Volatility
Apr 23, 2026 08:40AM Hims & Hers expands platform to include Eli Lilly weight loss medications
Apr 21, 2026 01:33PM Morgan Stanley Comments Eli Lilly (LLY) and Medicare GLP-1 Obesity Coverage
Apr 21, 2026 11:03AM Eli Lilly and Novo Nordisk shares fall as CVS opts out of Medicare obesity drug coverage
Apr 21, 2026 10:53AM CVS Health Opts Out Of Medicare Obesity Drug Coverage Model
Apr 16, 2026 08:40AM Walmart expands weight management services with virtual care platform
Apr 13, 2026 08:02AM Novo Nordisk (NVO) PT Lowered to $36 at BMO Capital
Apr 7, 2026 08:10AM Novo Nordisk launches higher-dose Wegovy for weight management
Apr 7, 2026 07:00AM Novo Nordisk repurchases 805,000 B shares worth DKK 186.5 million
Apr 2, 2026 08:47AM Novo Nordisk says Wegovy pill shows greater weight loss than Lilly rival
Mar 31, 2026 10:08AM Novo Nordisk (NVO) call put ratio 1.2 calls to 1 put
Mar 31, 2026 08:46AM LifeMD launches Novo Nordisk Wegovy subscription program
Mar 31, 2026 07:34AM Novo Nordisk launches discounted Wegovy subscription plan in US
Mar 31, 2026 06:57AM Novo Nordisk cuts Ozempic and Wegovy prices up to 48% in India
Mar 31, 2026 06:35AM Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'
Mar 30, 2026 08:24AM BMO Capital Checking In With Novo Nordisk (NVO) Ahead of 1Q26
Mar 29, 2026 10:00AM Should you buy the dip in Novo Nordisk stock? Wall Street analyst answers
Mar 27, 2026 05:12AM Canaccord on Hims and Hers (HIMS): 'Novo partnership goes live; near-term headwind to revenue, long-term tailwind to the story'
Mar 26, 2026 05:34AM Wolfe Research Starts Novo Nordisk (NOVOB:DC) (NVO) at Peerperform, 'no longer an obesity darling'
Mar 25, 2026 06:16AM Novo Nordisk (NVO) call put ratio 1.5 calls to 1 put
Mar 20, 2026 07:31AM India's Eris Lifesciences launches generic semaglutide at $13.8 per month
Mar 19, 2026 11:42AM Novo Nordisk gets FDA approval for higher-dose Wegovy HD weight-loss drug
Mar 18, 2026 01:50PM Bernstein SocGen Group Starts Novo Nordisk (NOVOB:DC) (NVO) at Underperform
Mar 18, 2026 08:55AM HIMS to offer Wegovy and Ozempic through partnership with Novo Nordisk
Mar 16, 2026 10:32AM Leerink on Structure Therapeutics (GPCR): 'Oral GLP-1 Achieves Best-In-Class Weight Loss'
Mar 13, 2026 10:09AM Hims shares set for best week on record after new Novo Nordisk deal
Mar 10, 2026 09:38AM Novo Nordisk issued FDA warning letter over adverse event reporting
Mar 10, 2026 08:50AM BMO Capital Shares Thoughts on Novo Nordisk (NVO) Following The Hims Agreement
Mar 10, 2026 08:27AM Novo Nordisk downgraded as pipeline 'not poised to blunt semaglutide LOE'
View Older Stories